Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.71

+0.4%

9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (1269)	6/28/2000 10:48:00 AM
From: Biomaven	Read Replies (3) of 52153

Miljenko: I am now positive that their [MLNM] next A target is CNS company. The question is which one and for what? Well there's not that many decent sized neuro companies. Looking down the list in a sample Neuroinvestment (for those that don't know it already, Dr Tracy's newsletter is one of the very few really good biotech newsletters - see sample issues at neuroinvestment.com ) CEPH GLFD IPIC (lower quality) NBIX NRGN SNAP TTP I would think that GLFD, NBIX and NRGN may be the best fits, or maybe SNAP if they want something cheap and want to play in the serotonin space. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next